2022 forecast: the year of the UPC?
Miha Creative / Shutterstock.com
As the dust settles following a turbulent year for IP, lawyers have cast their predictions for the pivotal issues and cases that will feature over the next 12 months.
In the third part of WIPR’s forecast series, leading lawyers offer their views on, what lies ahead for artificial intelligence in the IP landscape, and the beleaguered Patent Trial and Appeal Board’s (PTAB) likely future stance on the NHK-Fintiv rule and Arthrex-related requests for inter partes reviews of patents.
Read on to discover the key issues to look out for…
AI and IP: a ‘hot button issue’
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
To request a FREE 2-week trial subscription, use the same link but select the 'trial' option in the dropdown box. NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
AI, Fintiv, Arthrex, PTAB, inter partes review, patent applications, innovation, technology, prior art, inventorship, Federal Circuit, USPTO, AIA, IPRs